C
Capricor Therapeutics, Inc. Tech Stack
Cell and exosome-based therapeutics for rare genetic and infectious diseases
Capricor is a publicly traded biotech firm (NASDAQ: CAPR) developing cell therapies and engineered exosomes, with a clinical-stage focus on Duchenne muscular dystrophy and broader rare-disease applications. The tech stack reveals a manufacturing and compliance-heavy operation: Veeva Vault, LIMS, and ERP systems anchor regulatory workflows, while the hiring mix—weighted toward operations, quality, and healthcare roles with accelerating velocity—and project backlog (CAPA implementation, recall readiness, post-market surveillance) signal a company scaling from preclinical into clinical and manufacturing maturity.
Tech Stack 29 technologies
Core StackNetSuite Active Directory VMware Hyper-V AWS Intune Palo Alto Networks Smartsheet Salesforce Databricks Snowflake Tableau Power BI LIMS Veeva Vault ERP Azure Veeam SolarWinds PowerShell Veeva CrowdStrike Falcon Abnormal Security Rapid7 InsightVM KnowBe4 Adobe Acrobat Visio SuiteScript qPCR
What Capricor Therapeutics, Inc. Is Building
◆Challenges
- Ensuring assay reliability
- Ensuring sox compliance
- Inventory demands
- Building medical affairs function
- Post-market quality compliance
- Recall readiness
- Vendor oversight for complaints
- Address systemic barriers for patients
- Ensure compliance with regulatory requirements
- Production timelines
▲Active Projects
- Investigator-initiated studies
- Patient services infrastructure development
- Advisory board support
- Post-market surveillance & data analysis
- Recall readiness exercises
- Capa implementation
- Develop new animal models
- Optimize in vivo research best practices
- Preclinical imaging studies
- Real-world evidence opportunities
Hiring Activity
15 roles · 10 in 30d
Department
Seniority
Company intelligence